BRAF Mutation Is Associated With a Specific Cell Type With Features Suggestive of Senescence in Ovarian Serous Borderline (Atypical Proliferative) Tumors

American Journal of Surgical Pathology - United States
doi 10.1097/pas.0000000000000313
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Usefulness of Immunohistochemistry for the Detection of the BRAF V600E Mutation in Ovarian Serous Borderline Tumors

Oncology Reports
MedicineCancer ResearchOncology
2014English

MRI Appearance of Ovarian Serous Borderline Tumors of the Micropapillary Type Compared to That of Typical Ovarian Serous Borderline Tumors: Radiologic-Pathologic Correlation

Journal of Ovarian Research
GynecologyOncologyObstetrics
2018English

Correlation of FOXC1 Protein With Clinicopathological Features in Serous Ovarian Tumors

Oncology Letters
Cancer ResearchOncology
2015English

Altered eIF6 and Dicer Expression Is Associated With Clinicopathological Features in Ovarian Serous Carcinoma Patients

Modern Pathology
Forensic MedicinePathology
2008English

A Distinct Subset of Atypical Spitz Tumors Is Characterized by BRAF Mutation and Loss of BAP1 Expression

American Journal of Surgical Pathology
AnatomyForensic MedicinePathologySurgery
2012English

BRAFV600E-mutated Ovarian Serous Borderline Tumors Are at Relatively Low Risk for Progression to Serous Carcinoma

Oncotarget
Oncology
2019English

VISTA Expression Is Associated With a Favorable Prognosis in Patients With High-Grade Serous Ovarian Cancer

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2019English

Serous Tubal Intraepithelial Carcinomas Associated With High-Grade Serous Ovarian Carcinomas: A Systematic Review

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2017English

Enormous Ovarian Borderline Serous Cystic Fibroma in Postmenopausal Patient. A Case

World Journal of Gynecology & Womens Health
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy